Literature DB >> 1656962

A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells.

J R Ngaiza1, E A Jaffe.   

Abstract

Cleavage by thrombin of the platelet thrombin receptor exposes a new N-terminal segment SFLLRNPNDKYEPF (SFLL) which acts as a tethered ligand. The free peptide activates platelets and induces platelet aggregation. We now show that SFLL can also activate human umbilical vein endothelial cells (HUVEC) and induce rises in both cytosolic free calcium ([Ca2+]i) and prostacyclin (PGI2) production. These responses were time- and concentration-dependent and were similar to those for native thrombin except that they were not blocked by hirudin. Initial activation of HUVEC with thrombin desensitized the subsequent response to SFLL for both rises in [Ca2+]i and PGI2 production. Thus, SFLL alone can activate HUVEC and elevate [Ca2+]i and induce PGI2 production suggesting that the thrombin receptors on platelet and endothelial cells are functionally and structurally similar.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656962     DOI: 10.1016/0006-291x(91)91765-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides.

Authors:  E Van Obberghen-Schilling; U B Rasmussen; V Vouret-Craviari; K U Lentes; A Pavirani; J Pouysségur
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

2.  The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation.

Authors:  W F Bahou; B S Coller; C L Potter; K J Norton; J L Kutok; M S Goligorsky
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 3.  Protease-activated receptors start a family.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

4.  Mice lacking the thrombin receptor, PAR1, have normal skin wound healing.

Authors:  A J Connolly; D Y Suh; T K Hunt; S R Coughlin
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

5.  Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development.

Authors:  S J Soifer; K G Peters; J O'Keefe; S R Coughlin
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

6.  Cathepsin G and thrombin: evidence for two different platelet receptors.

Authors:  M A Selak
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

7.  Suppression of prostanoid formation and regulation of peripheral circulation after surgery using thrombin inhibitor (MD805).

Authors:  M Onizuka; S Ishikawa; O Ishibashi; M Suga; K Mitsui; T Mitsui
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

8.  Relaxant and contractile responses of porcine pulmonary arteries to a thrombin receptor activating peptide (TRAP).

Authors:  E Glusa; M Paintz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

9.  Thrombin receptor expression in normal and atherosclerotic human arteries.

Authors:  N A Nelken; S J Soifer; J O'Keefe; T K Vu; I F Charo; S R Coughlin
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells.

Authors:  H Mirza; V Yatsula; W F Bahou
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.